MERUS N.V.
MERUS N.V.
Share · NL0011606264 · MRUS · A2AKFX (XNMS)
Overview Financial Indicators
55,05 USD
-2,48 % -1,40 USD
NASDAQ/NMS (GLOBAL MARKET) (XNAS) · Current prices and charts at MoneyPeak
11.06.2025 20:00

Current Prices from MERUS N.V.

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
MRUS
USD
11.06.2025 20:00
55,05 USD
56,45 USD
-2,48 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % -1,71 % 34,60 % 15,70 % 27,64 % -3,61 % 258,63 %

Firmenprofil zu MERUS N.V. Aktie

Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also developing MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; MCLA-145, which is in phase 1 clinical trials for the treatment of solid tumors; MCLA-129, which is in phase 1/2 clinical trials for the treatment of patients with advanced non-small cell lung cancer and other solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat relapsed/refractory T cell lymphoma. In addition, it has collaboration agreement with Betta Pharmaceuticals Co. Ltd for the research and development of stage bispecific antibody candidates include MCLA-129; and collaboration with Incyte Corporation for the development of MCLA-145. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.

Unternehmensdaten

Name MERUS N.V.
Firma Merus N.V.
Symbol MRUS
Website https://www.merus.nl
Heimatbörse XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A2AKFX
ISIN NL0011606264
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Sven Ante Lundberg M.D.
Marktkapitalisierung 3 Mrd.
Land Niederlande
Währung USD
Mitarbeiter 0,3 T
Adresse Yalelaan 62, 3584 CM Utrecht
IPO Datum 2016-05-19

Ticker Symbole

Name Symbol
Frankfurt 2GH.F
NASDAQ MRUS

Weitere Aktien

Investoren die MERUS N.V. die halten, haben auch folgende Aktien im Depot:
CREDIT AGRI. 22/27 MTN
CREDIT AGRI. 22/27 MTN Anleihe
GOLDM.S.GRP 20/30
GOLDM.S.GRP 20/30 Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025